— Know what they know.
Not Investment Advice

MRES OTC

Institute of Biomedical Research Corp.
1W: -20.4% 1M: -56.2% 3M: +86.2% YTD: -37.5% 1Y: -71.8% 3Y: -93.1% 5Y: -89.5%
$0.00
-0.00 (-14.63%)
 
Weekly Expected Move ±26.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $4.8M mcap · 1.24B float · 0.128% daily turnover · Short 37% of daily vol

Balance Sheet Trends

Total Assets
$3M -5.0% ▼
5Y CAGR: +99.8%
Total Liabilities
$776K -17.1% ▼
5Y CAGR: +33.0%
Shareholders Equity
$584K -60.6% ▼
Cash & Investments
$12K -88.1% ▼
Total Debt
$0 +0.0% ▲
Net Debt
-$12K +88.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2009FY2010FY2022FY2023FY2024
— Assets —
Cash$0$0$5K$99K$12K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$0$0$5K$99K$12K
Net Receivables$0$0$68K$36K$36K
Inventory$0$0$5K$30K$19K
Other Current Assets$0$0$0$0$4
Total Current Assets$2K$0$217K$323K$108K
Property, Plant & Equip.$75K$62K$15K$11K$6K
Goodwill & Intangibles$0$0$18K$3M$3M
Long-Term Investments$0$0$192K-$68K$12K
Other Non-Current Assets$0$15K$197K$34K$0
Total Non-Current Assets$75K$76K$421K$3M$3M
Total Assets$78K$76K$638K$3M$3M
— Liabilities —
Accounts Payable$0$0$0$0$0
Short-Term Debt$0$402K$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$20K$283K$935K$683K
Total Current Liabilities$149K$422K$283K$935K$683K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$476K$0$93K
Total Non-Current Liabilities$0$0$476K$0$93K
Total Liabilities$149K$422K$759K$935K$776K
— Equity —
Common Stock$54K$53K$1M$2M$3M
Retained Earnings-$7M-$7M-$59M-$58M-$59M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$72K-$345K-$121K$1M$584K
Total Liabilities & Equity$78K$76K$638K$3M$3M
— Key Metrics —
Total Debt$0$402K$0$0$0
Net Debt$0$402K-$5K-$99K-$12K
Total Investments$0$0$192K-$68K$12K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms